advanced search

New Directions Technology Consulting

In the area of drug delivery, New Directions Technology Consulting is the exclusive market developer for the mMed patent portfolio. Medication telemanagement systems based on the portfolio can be used to develop innovative health and wellness programmes.


Visit Website

Company Address:
New Directions Technology Consulting LLC
Lancaster
PA 17601
United States

Phone / Contact

T: +1 718 427 3038
E: [email protected]

Connect

In the area of drug delivery, New Directions Technology Consulting is the exclusive market developer for the mMed patent portfolio. Medication telemanagement systems based on the portfolio can be used to develop innovative health and wellness programmes.

0

Articles by New Directions Technology Consulting

EXPERT VIEW
Napoleon Monroe
CONNECTIVITY IN HEALTHCARE – FROM THE MILLENNIUM TO THE PANDEMIC AND BEYOND
Napoleon Monroe looks back at the factors that influenced the underwhelming uptake of connectivity-enabling technologies in the healthcare sector over the first two decades of the 21st century, how the covid-19 pandemic changed everything and what current healthcare challenges connectivity might solve.
INDUSTRIALISATION
Napoleon Monroe
INDUSTRIALISATION OF DRUG DELIVERY BEYOND MANUFACTURING
Napoleon Monroe considers the impact of the changing technological landscape on how industrialisation in the healthcare industry is evolving, with reference to the idea of “patients as consumers” and how the relationship between consumers, information and industry has evolved in other sectors, such as tech and retail – and how big players in those sectors are looking to move into and disrupt healthcare.
CONNECTIVITY
Napoleon Monroe
PATENTS ARE IMPORTANT FOR SMART HEALTHCARE PRODUCTS
Napoleon Monroe discusses the value of internet-connected smart devices in present-day healthcare, and introduces the mMed patent portfolio, of which Mr Monroe is the sole inventor, and which contains five US patents for key connected health technologies.
EXPERT VIEW
Napoleon Monroe
COVID-19: A CATALYST FOR IMPLEMENTING CONNECTED HEALTHCARE PRODUCTS?
Napoleon Monroe analyses how covid-19 is catalysing a wide range of reactions in healthcare, explaining how drug and device connectivity are essential to improving patient access to treatment – and patient outcomes – as well as reducing overall cost. 
EXPERT VIEW
Napoleon Monroe
PATIENTS, MANUFACTURERS & PRACTITIONERS CAN LEAD ADOPTION OF CONNECTED COMBINATION PRODUCTS
Napoleon Monroe asks why connectivity has failed to advance rapidly, and argues that many stakeholders can benefit if the adoption of connectivity for drug delivery can be accelerated. While this article will centre on pharmaceutical combination products, the essential points also relate more broadly to pharmaceuticals and medical devices.
EXPERT VIEW
Napoleon Monroe
CONNECTIVITY RESTORING TRUST IN PHARMA COMMUNICATIONS
Napoleon Monroe analyses connectivity coverage at recent drug delivery conferences and, more broadly, in various publications, to evaluate the current direction, and explore the scope for connectivity to effect changes benefiting multiple stakeholders across a range of treatment categories.
EXPERT VIEW
Napoleon Monroe
CONNECTIVITY USING CONSUMER TECHNOLOGY TO CREATE REAL VALUE FOR PATIENTS
Napoleon Monroe presents the case for the C-Container, a collective term for a theoretical class of consumer product designed to work with various drug delivery combination products.
EXPERT VIEW
Napoleon Monroe
BEYOND MANUFACTURING: INDUSTRIALISATION OF DRUG DELIVERY IN THE REAL WORLD
When discussing the industrialisation of drug delivery, it is natural to focus on the processes and management of manufacture. Napoleon Monroe provides a different perspective on the idea of drug delivery’s “Industrialisation” and what that might mean in the modern world of service industry.
CONFERENCE REVIEW
Napoleon Monroe
CONNECTIVITY IN DRUG DELIVERY
Napoleon Monroe summarises the intensifying coverage of connectivity as a key theme at two recent drug delivery conferences he attended, Partnerships in Drug Delivery and PDA’s Universe of Prefilled Syringes and Injection Devices.
EXPERT VIEW
Napoleon Monroe
CONNECTED COMBINATION PRODUCTS: US ANALYSIS WITH POTENTIAL IMPLICATIONS WORLDWIDE
Napoleon Monroe provides an overview of the current status of connected combination products from the US perspective, with an emphasis on human factors, automated identity and regulation.
EXPERT VIEW
Napoleon Monroe
CONNECTED COMBINATION PRODUCTS: PAST, PRESENT & FUTURE
Napoleon Monroe provides an overview of connected health with a focus on drug delivery systems, beginning by showing that connected health has not suddenly emerged out of nowhere but, rather, it has been developing and evolving over many decades, even centuries.
Top